Rani Therapeutics enters into employment agreement for Nicholas M. Maestas
Rani Therapeutics LLC has issued an offer letter to Nicholas M. Maestas to serve as its new Chief Financial Officer, effective June 29, 2026. The hiring of a new CFO marks a significant leadership transition for the biotechnology company, potentially influencing its financial oversight and strategic direction.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day